Anticoagulants and skin necrosis.
Griffin
J P
JP
Association of the British Pharmaceutical Industry, London.
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D009336:Necrosis; D020151:Protein C Deficiency; D018455:Protein S Deficiency / Q000473:pathology; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D014813:Vitamin K Deficiency / Q000473:pathology
D000925:Anticoagulants; D003374:Coumarins; D006493:Heparin; C030123:coumarin